Combination of Fenofibrate with Non-Statin Drug Regimens

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|30|3401-3416

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.30, 2010-10, pp. : 3401-3416

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of quetiapine in combination regimens

By  

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions

By Davidson Michael H  

Expert Opinion on Drug Safety, Vol. 5, Iss. 1, 2006-01 ,pp. : 145-156

Informa Healthcare

Access to resources Recommend Favorite

Combination Therapy with Metformin and Fenofibrate for Insulin Resistance in Obesity

By Li X-M   Li Y   Zhang N-N   Xie Y-H   Shi Y-Q  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1876-1882

Field House Publishing

Access to resources Recommend Favorite

Combination chemotherapy regimens compared in NSCLC

By  

Inpharma, Vol. 1, Iss. 1243, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Statin-Associated Psychiatric Adverse Events: A Case/Non-Case Evaluation of an Italian Database of Spontaneous Adverse Drug Reaction Reporting

By Tuccori Marco   Lapi Francesco   Testi Arianna  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1115-1123

Adis International

Access to resources Recommend Favorite